Gastrointestinal Stromal Tumor (GIST) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors
Conditions: Progression-free Survival; Gastrointestinal Stromal Tumor; Neoadjuvant Intervention: Drug: Imatinib Sponsors: First Affiliated Hospital of Zhejiang University; Second Affiliated Hospital, School of Medicine, Zhejiang University; Sir Run Run Shaw Hospital; Zhejiang Cancer Hospital; First Affiliated Hospital of Wenzhou Medical University; Taizhou Hospital of Zhejiang Province ; Ningbo No. 1 Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2021 Category: Research Source Type: clinical trials
